Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • PI3K
    (2)
  • Akt
    (1)
  • Endogenous Metabolite
    (1)
  • Wnt/beta-catenin
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

me-143

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
ME-143
NV-143
T73478852536-39-1
ME-143, a second-generation tumor-specific NADH oxidase inhibitor, exhibits efficacy by inhibiting the WNT/β-catenin pathway in colorectal cancer cells. Demonstrating broad activity against cancers both in vitro and in vivo, this compound presents a promising therapeutic avenue.
  • $1,520
6-8 weeks
Size
QTY
Zandelisib
T133861401436-95-0
Zandelisib is an inhibitor of phosphatidylinositol 3-kinase (PI3K)(p110δ, IC50 of 3.5 nM), and with antineoplastic activity.
  • $77
In Stock
Size
QTY
Zandelisib hydrochloride
PWT-143 hydrochloride, ME-401 hydrochloride
T2109932839515-65-8
Zandelisib (ME-401) hydrochloride is a selective, orally active, non-covalent PI3Kδ inhibitor. It effectively and persistently inhibits AKT phosphorylation and downstream signaling pathways. Zandelisib hydrochloride is utilized in research on malignant tumors such as relapsed/refractory B-cell lymphoma.
  • Inquiry Price
10-14 weeks
Size
QTY